Web Results

en.wikipedia.org/wiki/Oscillococcinum

Oscillococcinum (or Oscillo) is a homeopathic preparation marketed to relieve influenza-like symptoms. It does not provide any benefit beyond that of sugar pills . It is a popular preparation, particularly in France. It is manufactured by Boiron, its sole manufacturer. Oscillococcinum is used in more than 50 countries and has ...

www.mywvbar.org/civicrm/file?reset=1&id=16189&eid=32216

Aug 29, 2017 ... 15-C-149. Nanack v. Organon USA, Inc. et al., No. 10-P-233; No. BER-L-2831-09 . RQdgers et al. v. Southwestern Energy Company, et al., No. 5:16-cv-00054-JPB. Zaken, et al. v. Charles, et al., No. 13-C-317. Bank Of America, N.A. v. Brown, No. 15-C-681-B. Boggs v. FIA Card Services, N. A., No. 13-C-834- ...

www.mywvbar.org/civicrm/file?reset=1&id=16185&eid=32207

Organon USA, Inc., et al., No. 10-P-233; No. BER-L-2831-09 Ohio. Rodgers et al. v. Southwestern Energy Company, et al., No. 5:16-cv-00054-JPB Ohio. Zaken, et al. v. Charles, et al., No. 13-C-317 Ohio. Bank Of America, N.A. v. Brown, No. 15- C-681-B Raleigh. Boggs v. FIA Card Services, N.A., No. 13-C-834-B Raleigh.

www.leagle.com/decision/1987472132ad2d3401417

Dec 18, 1987 ... In the Matter of Billie Boggs, an Alleged Mentally Ill Patient, Respondent, v. New York City Health and Hospitals Corporation et al., Appellants ...... We have held in City Univ. v Finalco, Inc. ( 129 A.D.2d 494 , 495 [1st Dept 1987]), that "[f]indings of fact [of a trial court] should not be disturbed unless such ...

www.leagle.com/decision/19941311849fsupp46211233

Thomas F. BOGGS, et al. ... This is a declaratory judgment action wherein Plaintiff seeks to have this court declare that ERISA, 29 U.S.C. § 1001 et seq., preempts Louisiana's community property laws. ... The entirety of these funds were "rolled over" into an IRA account at Delaware Charter Guarantee Trust Company.

citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.969.4595&rep=rep1&type=pdf

quetiapine XR (50–300mg/d) monotherapy improved symptoms of sleep disturbance vs. placebo in patients with MDD, including those with either ... 16.6 % in the USA (Kessler et al., 2005) and 12.8% in. Europe (Alonso et al., 2004). ...... (Organon Pharmaceuticals Inc.), Alkermes, AstraZeneca,. Axon Advisors, Bristol-Myers ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4049075

Objectives. Galantamine is an acetylcholinesterase inhibitor and an allosteric modulator of the α4β2 and α7 nicotinic receptors. There are several case reports describing the potential benefits of galantamine for negative symptoms associated with schizophrenia. This secondary analysis describes the effects of galantamine ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3717343

Weight gain is a major adverse effect of several second-generation antipsychotic medications. Rimonabant is a cannabinoid-1 receptor antagonist that promotes weight loss in the general population. We conducted a 16-week, double-blind, placebo-controlled study of rimonabant (20 mg/d) in people with schizophrenia or  ...

archive.org/stream/de-materia-medica/scribd-download.com_dioscorides-de-materia-medica_djvu.txt

885 POISONOUS MATERIALS — 926 V for Laura THE HERBAL OF DIOSCORIDES THE GREEK EDITORIAL PREFACE P edanius Dioscorides the Greek wrote this DeM ..... Pauly s Real-Encyclopadie der classischen altertumswissenschaft, Wissowa, George et al, editors, Metzler, Wien 1894-( supplement in progress).